Dr. Esther H. Chang joined the Georgetown Lombardi Comprehensive Cancer Center as a Professor of Oncology and Otolaryngology and she is still on staff there today in 1996. She received her bachelor’s degree from Fu Jen University in Taiwan and her Ph.D. from Southern Illinois University. Following her doctoral research, she held various positions at the National Institute of Health, the National Cancer Institute (NCI), the Uniformed Services University of the Health Sciences, and Stanford University Medical Center. In addition to teaching and conducting research, she is the President of the American Society for Nanomedicine and is an Executive Board Member of the International Society for Nanomedicine. She is the inventor or co-inventor of 115 issued patents and is the founding scientist and senior consultant for SynerGene Therapeutics, Inc., a privately held company that has five ongoing clinical trials for two nanomedicines. Throughout her career, she has published over 140 scientific articles and has served as a member of the scientific boards for the National Cancer Institute, NASA, the U.S. Military Cancer Institute, and the Department of Energy.
